Vaccines - AstraZeneca, Moderna and Pfizer - W... - CLL Support

CLL Support

23,682 members40,432 posts

Vaccines - AstraZeneca, Moderna and Pfizer - Which one for CLL Patients.

RobertCLL profile image
17 Replies

I had a telephone consultation with my CLL consultant today (I would consider her to be a UK expert in CLL). We discussed 3 of the vaccines, AstraZeneca, Moderna and Pfizer. As the latter 2 manufacturers are mRNA, the first (The AstraZeneca/Oxford vaccine is a genetically modified common cold virus of infected chimpanzees). She therefore instructed me NOT to receive the AstraZeneca/Oxford vaccine as this is a weakened (or attenuated) form of the germ.

I suspect that her comment may be controversial, so just providing the feedback I have received.

Written by
RobertCLL profile image
RobertCLL
To view profiles and participate in discussions please or .
17 Replies
Poodle2 profile image
Poodle2

Strange, I had a telephone consultation with my consultant today as well, in the UK, she said I should take any vaccine that will be offered. This is a bit confusing that doctors in the same country say different things. She is also a CLL specialist. Not sure what to think of this ...thanks for sharing.

AussieNeil profile image
AussieNeilPartnerAdministrator in reply toPoodle2

The confusion lies in the simplification for us to 'Avoid live vaccines', which could be expressed more exactly but less effectively as 'Avoid live vaccines capable of infecting you', which then causes uncertainty of which live vaccines we can and can't take. The need for clarification also wasn't an issue with traditional vaccines. That's because the AstraZeneca/Oxford vaccine uses a genetically modified chimpanzee adenovirus to deliver the SARS-CoV-2 spike protein into our cells to encourage an immune response. The genetically modified chimpanzee adenovirus is not capable of replicating in humans - even if immune compromised.

This Forbes article explains the process:

forbes.com/sites/alexknapp/...

Neil

wmay13241 profile image
wmay13241 in reply toAussieNeil

If you IgG has been compromised by cancer treatments, the AstraZeneca vaccine may not be the best choice. This is particularly true if you get IVIG infusions.

AussieNeil profile image
AussieNeilPartnerAdministrator in reply towmay13241

Why is that? Do you have a reference and if so, does it explain why it is particularly true if you have IVIG infusions and does it matter whether your need for them was before or after treatment? Many of us get IgG infusions, so this is important.

Thanks,

Neil

mrsjsmith profile image
mrsjsmith in reply toAussieNeil

Agreed Neil,

And the first I have heard of this problem and I would imagine because that is the one the UK have ordered the most of it will be the one I receive.

Colette

wmay13241 profile image
wmay13241 in reply toAussieNeil

My understanding is that the AstraZeneca vaccine works by altering your IgG to recognize and destroy covid-19. If your immunoglobulins are compromised, say by CAR-T, and your IgG requires IVIG infusions to replenish your IgG, then a vaccine based on IgG will not last long.

cajunjeff profile image
cajunjeff in reply towmay13241

That’s an efficacy issue. The original post was based on the premise that the Oxford vaccine is unsafe for us because it’s a live vaccine.

As Neil explained, it’s not a traditional live vaccine. It’s not a weakened form of the covid virus which could cause us to get covid. It’s a vector vaccine. I have not seen anywhere where vector vaccines are not safe for us.

With any vaccine we with Cll take there will be questions about it’s efficacy.

RobertCLL profile image
RobertCLL in reply toPoodle2

I guessed that we were all going to receive different advice.

ornstin profile image
ornstin

These opinions by CLL experts seem to me premature. The AstraZeneca vaccine hasn't even been approved. Its also some way off (months?) before CLL patients will be offered vaccination (so I don't understand the need for advice to be given on vaccines right now) by which time I would expect that more vaccines will have been approved, more data will be available, on which basis there would be guidance on which vaccine or vaccine should be given to the extremely vulnerable, both on the grounds of efficacy and safety. It would be surprising if the guidance just turned out to be "take any vaccine that is offered". I would find that advice a bit worrying, but I suppose it cannot be ruled out.

mrsjsmith profile image
mrsjsmith in reply toornstin

My Consultant when asked said it was too early to say. As I understand the AstraZeneca is continuing testing on an older trial group. To be honest in the UK if we suddenly get a text or call from our surgeries to go in for the vaccine I doubt if the receptionist will know what we are being offered. They never know which flu vaccine I am going to get !

Colette

ornstin profile image
ornstin in reply tomrsjsmith

Thank you. I am actually fairly hopeful we will know which vaccine we will be getting when the time comes. This could become a fairly hot topic.

LeoPa profile image
LeoPa in reply tomrsjsmith

Your consultant is smart. Too early to say is another version of "I don't know*. Only smart people say that. The rest knows everything and have been everywhere (twice at least) 😁

Pageboy profile image
Pageboy

I overheard my doctor the other day replying to a patient who was just leaving answer their question about which Covid jab he should get, to have any one which is offered (this wasn’t a confidential conversation btw!). The man was about 90. I don’t know on the balance of risk given his age my doctor considers the vaccine a must for him. But he didn’t sound at all concerned recommending any of the vaccines. I haven’t had the conversation myself with him yet, beyond I should get the vaccine in a few months as I’ve just started treatment.

Berrytog profile image
Berrytog

Which vaccine may well depend on which medication CLL patients are already taking. I have read of trials taking place to not just determine the suitability but to see the benefits of our drugs as a partial defence against Covid 19 reducing symptoms and the need for hospitalisation even in the older patients which represent a majority of CLL patients.

RobertCLL profile image
RobertCLL

Not directly related. But just seen this on the CLLforum website:

Anti COVID vaccines should be strongly encouraged for all close contacts of CLL patients who are immunocompetent. CLL patients must not receive live vaccines (follow Department on Health advice on COVID vaccines for immunocompromised).

Section 12 of the following link:

ukcllforum.org/wp-content/u...

RobertCLL profile image
RobertCLL

I have just been pointed in the direction of CLL Support, with the following guidance:

images.cllsupport.org.uk/wp...

To quote: "In consultation with CLL specialists at the UK CLL Forum, we understand that the newly approved Pfizer/BioNTech coronavirus vaccine and AstraZeneca's vaccine awaiting approval are both nonreplicating, RNA or subunit vaccines. This is good news for the CLL community. Neither vaccine is ‘live’. There should be no safety concerns for immunocompromised patients, whichever vaccine you are offered".

Interesting why members of the UK CLL Forum are offering different advice.

Big_Dee profile image
Big_Dee

Hello RobertCLL

I would suspect your CLL Specialist is correct.

Not what you're looking for?

You may also like...

*IMPORTANT* ALL COVID-19 Vaccines are thought to be safe for CLL Patients- they are NOT live vaccines and cannot cause illness

There has been much concern following the statement by Prof Salisbury on BBC24 stating that the...
Jm954 profile image
Administrator

CLL and mRNA Vaccines

Just saw this abstract, which is one of the papers being presented at the Boston CLL conference:...
BWHR profile image

Suitability of 3 Current Vaccines for CLL 'ers

Just thought I would update on the advice which I have just got from my NHS consultant at Royal...

Covid vaccine for CLL patients

Is there a thread for research on Covid vaccine for CLL patients?
JIDD profile image

Re vaccine and outcome for CLL you might find this interesting

Today, the first results of a key study on vaccine responses in leukaemia patients has been...